Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

MSD (Merck & Co) has won US Food and Drug Administration (FDA) approval for its cholesterol-lowering pill, marking a significant milestone in the drugmaker’s push to reduce revenue reliance on ...

The FDA has issued traditional approval to Novartis for Fabhalta to slow the decline of kidney function in adults with primary IgAN who are at risk of disease progression.

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for oral Wegovy (semaglutide). The European Commission (EC) granted m ...

Harbour BioMed and Kelun-Biotech have received approval from China’s NMPA for their IND application for the HBM7575/SKB575 bispecific antibody intended to treat asthma.

Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments.

AdvanCell will use the mega-round earnings to progress ADVC001 and build radiopharmaceutical manufacturing infrastructure.

From crude chemical and protein measurements to the advent of sophisticated precision medicine strategies, biomarkers are reshaping the future of nephrology research. This article charts the evolution ...

The pharma industry welcomed the pledge, which marked the first-time drug IP has explicitly been stated in a free trade agreement ...

Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.